Social media

ICON is proud to be at ISPOR Europe 2025 in Glasgow. Let’s talk about: - Health economics & outcomes research - Real-world evidence - Patient-centred value strategies Together, we can power value and access in healthca...

ICON is proud to be at ISPOR Europe 2025 in Glasgow. Let’s talk about: - Health economics & outcomes research - Real-world evidence - Patient-centred value strategies Together, we can power value and access in healthca...

In this new blog series, we review ISO 14971 (Application of risk management to medical devices) - its history, the principles embedded within it and how it relates to other standards and regulation. For the first editio...

In this new blog series, we review ISO 14971 (Application of risk management to medical devices) - its history, the principles embedded within it and how it relates to other standards and regulation. For the first editio...

Meet ICON experts at the AASLD to learn how ICON partners with sponsors, investigators, patients and other collaborators to deliver strategic, data-driven solutions for MASH and hepatology studies. https://ow.ly/9QBn50X8...

Meet ICON experts at the AASLD to learn how ICON partners with sponsors, investigators, patients and other collaborators to deliver strategic, data-driven solutions for MASH and hepatology studies. https://ow.ly/szmf50X8...

Digital measures, including digital biomarkers and digital endpoints, offer sponsors powerful ways to assess treatment effect in real time, in the real world. But to be meaningful, those measures must be carefully selec...

Teams incorporating DHTs into their protocol design may grapple with the question of how to transform raw sensor data into a validated, regulatory-ready digital endpoint. Start with the V3 framework: 🔬 Verification 📊...

The PHUSE single day event in Bloemfontein will bring together leading professionals to explore innovations shaping clinical data science. ICON is proud to contribute to these discussions, focusing on topics such as digi...

Post-marketing pharmacovigilance plays a crucial role in maintaining patient safety once a product reaches the market. While automation can streamline certain tasks, its implementation must be carefully managed to avoid ...

Post-marketing pharmacovigilance plays a crucial role in maintaining patient safety once a product reaches the market. While automation can streamline certain tasks, its implementation must be carefully managed to avoid ...

Early clinical trial designs—especially first-in-human (FIH) studies—are increasingly tailored to the unique needs of specific therapeutic areas. In neurodegenerative diseases, there is a growing shift toward flexible an...